Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Successful Engraftment of Cord Blood Transplantation Following Reduced-Intensity Conditioning Regimen Using Fludarabine and Busulfan for Advanced Hematologic Malignancies.

Yuji Satou, MD, PhD, Toshiro Nagasawa, MD, PhD, Takayuki Azuma, MD, Yuji Miura, MD, Tsunehiko Komatsu, MD, PhD

Blood (2007) 110 (11): 5066.

https://doi.org/10.1182/blood.V110.11.5066.5066

Published: 2007

Journal Articles

Transgene Insertion into the Proximity of the c-myb Gene Disrupts Erythroid-Megakaryocytic Lineage Bifurcation.

Harumi Yamamoto Mukai, MD, PhD, Hozumi Motohashi, MD, PhD, Toshiro Nagasawa, MD, PhD, Masayuki Yamamoto, MD, PhD

Blood (2006) 108 (11): 1172.

https://doi.org/10.1182/blood.V108.11.1172.1172

Published: 2006

Journal Articles

GATA-1, Transcriptionally, and Thrombopoietin-Mediated Akt Activation, Post-Translationally, Regulate Continuous Expression of Bcl-xL Protein during Megakaryopoiesis.

Yukinori Kozuma, Hiroshi Kojima, MD, PhD, Satoshi Yuki, Hidenori Suzuki, PhD, Toshiro Nagasawa, MD, PhD

Blood (2006) 108 (11): 1140.

https://doi.org/10.1182/blood.V108.11.1140.1140

Published: 2006

Journal Articles

High Alloreactive Potential of Central Memory T-Lymphocytes Expressing a Suicide Gene for the Cure of Hematologic Malignancies.

Shin Kaneko, MD, PhD, Sara Mastaglio, MD, Attilio Bondanza, MD, Maurilio Ponzoni, MD, Luca Aldrighetti, MD, Salvatore Toma, PhD, Marina Radrizzani, PhD, Simona La Seta Catamancio, PhD, Fabio Ciceri, MD, Toshiro Nagasawa, MD,PhD, Claudio Bordignon, MD,PhD, Chiara Bonini, MD

Blood (2006) 108 (11): 3265.

https://doi.org/10.1182/blood.V108.11.3265.3265

Published: 2006

Journal Articles

Regulation of the Anti-Apoptotic Protein, Bcl-xL, during Differentiation of Megakaryocytes from Stem Cells.

Hiroshi Kojima, MD, PhD, Yukinori Kozuma, Toshiro Nagasawa, MD, PhD

Blood (2005) 106 (11): 3146.

https://doi.org/10.1182/blood.V106.11.3146.3146

Published: 2005

Journal Articles

2-Oxoglutarate Down-Regulates Expression of Vascular Endothelial Growth Factor and Erythropoietin through Decreasing Hypoxia Inducible Factor-1 α and Inhibits Angiogenesis.

Shigehiko Imagawa, MD, PhD, Ken Matsumoto, PhD, Naoshi Obara, M.D, Norio Suzuki, PhD, Toshiro Nagasawa, MD, PhD, Masayuki Yamamoto, MD, PhD

Blood (2005) 106 (11): 3957.

https://doi.org/10.1182/blood.V106.11.3957.3957

Published: 2005

NARROW

Successful Engraftment of Cord Blood Transplantation Following Reduced-Intensity Conditioning Regimen Using Fludarabine and Busulfan for Advanced Hematologic Malignancies.

Transgene Insertion into the Proximity of the c-myb Gene Disrupts Erythroid-Megakaryocytic Lineage Bifurcation.

GATA-1, Transcriptionally, and Thrombopoietin-Mediated Akt Activation, Post-Translationally, Regulate Continuous Expression of Bcl-xL Protein during Megakaryopoiesis.

High Alloreactive Potential of Central Memory T-Lymphocytes Expressing a Suicide Gene for the Cure of Hematologic Malignancies.

Regulation of the Anti-Apoptotic Protein, Bcl-xL, during Differentiation of Megakaryocytes from Stem Cells.

2-Oxoglutarate Down-Regulates Expression of Vascular Endothelial Growth Factor and Erythropoietin through Decreasing Hypoxia Inducible Factor-1 α and Inhibits Angiogenesis.

Email alerts

ASH Publications

American Society of Hematology

Successful Engraftment of Cord Blood Transplantation Following Reduced-Intensity Conditioning Regimen Using Fludarabine and Busulfan for Advanced Hematologic Malignancies.

Transgene Insertion into the Proximity of the c-myb Gene Disrupts Erythroid-Megakaryocytic Lineage Bifurcation.

GATA-1, Transcriptionally, and Thrombopoietin-Mediated Akt Activation, Post-Translationally, Regulate Continuous Expression of Bcl-xL Protein during Megakaryopoiesis.

High Alloreactive Potential of Central Memory T-Lymphocytes Expressing a Suicide Gene for the Cure of Hematologic Malignancies.

Regulation of the Anti-Apoptotic Protein, Bcl-xL, during Differentiation of Megakaryocytes from Stem Cells.

2-Oxoglutarate Down-Regulates Expression of Vascular Endothelial Growth Factor and Erythropoietin through Decreasing Hypoxia Inducible Factor-1 α and Inhibits Angiogenesis.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only